Senate panel opens inquiry into EpiPen pricing


September 7, 2016 11:00PM (UTC)

WASHINGTON (AP) — A Senate panel has opened a preliminary investigation into why the price of lifesaving EpiPens has skyrocketed.

The top Republican and Democrat on the Senate Homeland's investigations subcommittee said in a statement Wednesday that they began an inquiry into Mylan Pharmaceuticals' pricing and competition practices. Mylan has been sharply criticized for its steep price increases for the emergency allergy treatment EpiPen.

Advertisement:

The price has grown to $608 for a two-pack, up more than 500 percent since 2007. The drugmaker has announced it will launch a generic version that will cost $300 in the next several weeks.

GOP Sen. Rob Portman of Ohio and Democratic Sen. Claire McCaskill of Missouri head the panel.

Heather Bresch, CEO of the pharmaceutical company, is the daughter of Democratic Sen. Joe Manchin of West Virginia.


BROWSE SALON.COM
COMPLETELY AD FREE,
FOR THE NEXT HOUR

Read Now, Pay Later - no upfront
registration for 1-Hour Access

Click Here
7-Day Access and Monthly
Subscriptions also available
No tracking or personal data collection
beyond name and email address

•••





Fearless journalism
in your inbox every day

Sign up for our free newsletter

• • •